Guidelines for COVID-19 antivirals revealed but GPs warned of shortages

The first stocks will be held in the National Medical Stockpile

The first Australian guidelines for the two new COVID-19 antivirals that GPs can prescribe warn that one of them  molnupiravir  should be prescribed only as a last resort.  


The Federal Government has ordered 500,000 courses of nirmatrelvir-ritonavir (Paxlovid) and 300,000 courses of molnupiravir (Legavrio), but global demand has left both drugs in short supply.

As a result it is expected that initially GPs will initially access them through the National Medical Stockpile